Showing results (231-240 of 239) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 239 results.
Environmental Science and Pollution Research International|September 24, 2021
Temperature affects growth, geosmin/2-methylisoborneol production, and gene expression in two cyanobacterial speciesQingyue Shen, Qian Wang, Hanchen Miao, et al.
Water Research|May 8, 2023
Highly efficient carbon assimilation and nitrogen/phosphorus removal facilitated by photosynthetic O2 from algal-bacterial aerobic granular sludge under controlled DO/pH operationZejiao Li, Jixiang Wang, Jialin Liu, et al.
Cancers|August 23, 2020
Novel Caffeic Acid Phenethyl Ester-Mortalin Antibody Nanoparticles Offer Enhanced Selective Cytotoxicity to Cancer CellsJia Wang, Priyanshu Bhargava, Yue Yu, et al.
Bioscience, Biotechnology, and Biochemistry|October 18, 2021
Dynamics of the prokaryotic and eukaryotic microbial community during a cyanobacterial bloomYilin Qian, Kunihiro Okano, Miwa Kodato, et al.
International Journal of Biological Sciences|July 7, 2023
Erratum: CD151 promotes Colorectal Cancer progression by a crosstalk involving CEACAM6, LGR5 and Wnt signaling via TGFβ1: ErratumTao Yang, Huibing Wang, Meng Li, et al.
International Journal of Biological Sciences|March 26, 2021
CD151 promotes Colorectal Cancer progression by a crosstalk involving CEACAM6, LGR5 and Wnt signaling via TGFβ1Tao Yang, Huibing Wang, Meng Li, et al.
Medicine|May 17, 2018
Therapeutic experience of severe and recurrent secondary hyperparathyroidism in a patient on hemodialysis for 18 years: A case reportMingwen Zhu, Zongming Zhang, Fangcai Lin, et al.
International Journal of Radiation Oncology, Biology, Physics|December 6, 2025
CapeOX Versus Capecitabine in Neoadjuvant Chemoradiation for High-Risk Locally Advanced Rectal Cancer: Long-Term Results From MONT-R Randomized Controlled TrialJiaolin Zhou, Ganbin Li, Wenzhuo Jia, et al.
Cancer Communications (London, England)|July 24, 2026
Short-Course Radiotherapy-Based Total Neoadjuvant Therapy plus Tislelizumab for Locally Advanced Rectal Cancer (Neo-STAR): Early Outcomes of a Randomized Phase II TrialFengpeng Wu, Xuhua Hu, Baokun Li, et al.
Pageof 24